STENDRA (avanafil) is a particular inhibitor of cGMP-explicit PDE5.

 Avanafil is assigned artificially as (S)- 4- [(3-Chloro-4-methoxybenzyl) amino] -2- [2-(hydroxymethyl)- 1-pyrrolidinyl]-N (2-pyrimidinylmethyl)- 5-pyrimidinecarboxamide

 Avanafil happens as white translucent powder, atomic equation C23H26ClN7O3 and sub-atomic load of 483.95 and is marginally dissolvable in ethanol, for all intents and purposes insoluble in water, solvent in 0.1 mol/L hydrochloric corrosive. STENDRA, for oral organization, is provided as oval, light-yellow tablets containing 50 mg, 100 mg, or 200 mg avanafil debossed with measurement qualities. Notwithstanding the dynamic fixing, avanafil, every tablet contains the accompanying latent fixings: mannitol, fumaric corrosive, hydroxypropyl cellulose, low subbed hydroxypropyl cellulose, calcium carbonate, magnesium stearate, and ferric oxide yellow.

Related Post

Leave a Reply

Your email address will not be published.